Emerging Molecular Diagnostics Market 2025-2029
The emerging molecular diagnostics market is forecasted to grow by USD 3.80 bn during 2024-2029, accelerating at a CAGR of 6.4% during the forecast period. The report on the emerging molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by prevalence of chronic diseases, increasing global geriatric population, and rising prevalence of neurological disorders.
Technavio's emerging molecular diagnostics market is segmented as below:
By Technology
- PCR
- NGS
- Microarray technologies
- Others
By End-user
- Hospitals and clinics
- Diagnostics laboratories
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the product launches associated with emerging molecular diagnostics as one of the prime reasons driving the emerging molecular diagnostics market growth during the next few years. Also, strategic partnerships between vendors and integration of ai with molecular diagnostics will lead to sizable demand in the market.
The report on the emerging molecular diagnostics market covers the following areas:
- Emerging Molecular Diagnostics Market sizing
- Emerging Molecular Diagnostics Market forecast
- Emerging Molecular Diagnostics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading emerging molecular diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Danaher Corp., ELITechGroup SAS, F. Hoffmann La Roche Ltd., Freenome Holdings Inc, GRAIL Inc, Hologic Inc., Invitae Corp., Natera Inc., OmniScience, Paragonix Technologies Inc., Siemens Healthineers AG, Solone Life Sciences India Pvt. Ltd., Thermo Fisher Scientific Inc., U Gen Biotechnology Inc., and Veracyte Inc.. Also, the emerging molecular diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.